Cargando…

COVID-19: opening a new paradigm in thromboprophylaxis for critically ill patients?

Detalles Bibliográficos
Autores principales:	Ferrandis, Raquel, Llau, Juan V., Quintana, Manuel, Sierra, Pilar, Hidalgo, Francisco, Cassinello, Concepción, Gómez-Luque, Aurelio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289223/ https://www.ncbi.nlm.nih.gov/pubmed/32527286 http://dx.doi.org/10.1186/s13054-020-03052-9

Ejemplares similares

Management of perioperative thromboprophylaxis for surgery following COVID-19: an expert-panel survey
por: Ferrandis, Raquel, et al.
Publicado: (2021)

SEDAR-SEMICYUC consensus on the management of haemostasis disorders in severe COVID-19 patients()
por: Llau, J.V., et al.
Publicado: (2021)

Prevention of the renarrowing of coronary arteries using drug-eluting stents in the perioperative period: an update
por: Llau, Juan V, et al.
Publicado: (2010)

SEDAR-SEMICYUC consensus recommendations on the management of haemostasis disorders in severely ill patients with COVID-19 infection()
por: Llau, J.V., et al.
Publicado: (2020)

Consenso SEDAR-SEMICYUC sobre el manejo de las alteraciones de la hemostasia en los pacientes COVID-19 graves
por: Llau, J.V., et al.
Publicado: (2021)

Recomendaciones de consenso SEDAR-SEMICYUC sobre el manejo de las alteraciones de la hemostasia en los pacientes graves con infección por COVID-19
por: Llau, J.V., et al.
Publicado: (2020)

Effectiveness of thromboprophylaxis with low molecular weight heparin in critically ill patients with COVID-19. An observational prospective, multicenter study
por: Ferrandis, R., et al.
Publicado: (2023)

Renal function and thromboprophylaxis in critically ill patients
por: Scholey, Gareth M, et al.
Publicado: (2010)

Thromboprophylaxis in Critically Ill Coronavirus Disease 2019 Patients
por: Piagnerelli, Michaël, et al.
Publicado: (2020)

Intensified thromboprophylaxis in COVID-19 critically ill patients: Is it enough?
por: de Montmollin, Etienne, et al.
Publicado: (2021)

New Paradigms of Extended Thromboprophylaxis in Medically Ill Patients
por: MacDougall, Kira, et al.
Publicado: (2020)

Adequate thromboprophylaxis in critically ill patients
por: Levi, Marcel
Publicado: (2010)

Perioperative Management of Antiplatelet-Drugs in Cardiac Surgery
por: Ferrandis, Raquel, et al.
Publicado: (2009)

Heparin thromboprophylaxis in critically ill patients: Is it really changing outcome?
por: Gurjar, Mohan
Publicado: (2014)

Dosing of thromboprophylaxis and mortality in critically ill COVID-19 patients
por: Jonmarker, Sandra, et al.
Publicado: (2020)

Enhanced thromboprophylaxis in critically ill patients with COVID-19 infection
por: Kummer, R.L., et al.
Publicado: (2021)

Thromboprophylaxis with argatroban in critically ill patients with sepsis: a review
por: Bachler, Mirjam, et al.
Publicado: (2022)

Observational study on fluid therapy management in surgical adult patients
por: Colomina, Maria J., et al.
Publicado: (2021)

Thromboprophylaxis in critical care
por: Helms, Julie, et al.
Publicado: (2022)

Standard- versus intermediate-dose enoxaparin for anti-factor Xa guided thromboprophylaxis in critically ill patients with COVID-19
por: Hamilton, David Oliver, et al.
Publicado: (2021)

Thromboprophylaxis patterns and determinants in critically ill patients: a multicenter audit
por: Lauzier, François, et al.
Publicado: (2014)

Periprocedural Direct Oral Anticoagulant Management: The RA-ACOD Prospective, Multicenter Real-World Registry
por: Ferrandis, Raquel, et al.
Publicado: (2020)

Anti-Xa Directed Thromboprophylaxis in Critically Ill Patients with Coronavirus Disease 2019
por: Mohamed, Adham, et al.
Publicado: (2022)

What Do We Know about Thromboprophylaxis and Its Monitoring in Critically Ill Patients?
por: Cauchie, Philippe, et al.
Publicado: (2021)

Thromboprophylaxis strategies for COVID-19 patients
por: Porres-Aguilar, Mateo, et al.
Publicado: (2022)

Risk factors for and prediction of mortality in critically ill medical–surgical patients receiving heparin thromboprophylaxis
por: Li, Guowei, et al.
Publicado: (2016)

Pharmacological and Mechanical Thromboprophylaxis in Critically Ill Patients: a Network Meta-Analysis of 12 Trials
por: Park, Jonghanne, et al.
Publicado: (2016)

Pragmatic study of a thromboprophylaxis algorithm in critically ill patients with SARS-COV-2 infection
por: Fattorutto, Maurizio, et al.
Publicado: (2021)

Toxic epidermal necrolysis: a paradigm of critical illness
por: Estrella-Alonso, Alfonso, et al.
Publicado: (2017)

Pharmacologic therapeutic options for thromboprophylaxis in COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2020)

The use of antiplatelet agents for arterial thromboprophylaxis in COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2021)

A validated clinical-genetic score for assessing the risk of thrombosis in patients with COVID-19 receiving thromboprophylaxis
por: Soria, José Manuel, et al.
Publicado: (2022)

Antifactor Xa Levels in Critically Ill Korean Patients Receiving Enoxaparin for Thromboprophylaxis: A Prospective Observational Study
por: Lim, So Yeon, et al.
Publicado: (2013)

High level of venous thromboembolism in critically ill trauma patients despite early and well-driven thromboprophylaxis protocol
por: Hamada, S. R., et al.
Publicado: (2017)

A comparison of three thromboprophylaxis regimens in critically ill COVID-19 patients: An analysis of real-world data
por: Alrashed, Ahmed, et al.
Publicado: (2022)

Coronavirus disease 2019 in pregnancy: consider thromboembolic disorders and thromboprophylaxis
por: Di Renzo, Gian Carlo, et al.
Publicado: (2020)

Insulin and the critically ill
por: Das, Undurti N
Publicado: (2002)

Efficacy and Safety of Two Different Enoxaparin Doses for Thromboprophylaxis in Non-critically Ill Patients: A Randomized Controlled Trial
por: Alavi-Darazam, Ilad, et al.
Publicado: (2022)

Mortality data from omission of early thromboprophylaxis in critically ill patients highlights the importance of an individualised diagnosis-related approach
por: Sahle, Berhe W., et al.
Publicado: (2023)

Pharmacological Thromboprophylaxis after Major Abdominal Surgery: Should the Duration be Individualized?
por: Papageorgopoulou, Chrysanthi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mntb9ctm8p1bs60unsidoh8mnm